Phibro Animal Health | PAHC - Operating Profit


Phibro Animal Health reported $54.99M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Align Technology USD 191.32M 13.27M Jun/2026
ANI Pharmaceuticals USD 39.84M 1.13M Jun/2026
Aurora Cannabis CAD -10.03M 25.76M Mar/2026
Bristol-Myers Squibb USD 299M 3.07B Jun/2026
Canopy Growth CAD -27.47M 14.81M Mar/2026
Corcept Therapeutics USD 41.3M 90.9M Jun/2026
Eli Lilly USD 12.46B 2.68B Jun/2026
Henry Schein USD 200M 18M Jun/2026
Idexx Laboratories USD 425.57M 62.98M Jun/2026
Knight Therapeutics CAD 6.21M 3.27M Dec/2025
Merck USD 840M 2.72B Jun/2026
Nektar Therapeutics USD -38.26M 19.17M Mar/2026
Pacira USD 9.96M 5.33M Jun/2026
Phibro Animal Health USD 54.99M 2.36M Dec/2025
Prestige Brands USD 52.52M 22.97M Jun/2026
Supernus Pharmaceuticals USD -21.04M 14.21M Jun/2026
Zoetis USD 1.12B 256M Jun/2026